THERABIOGEN, INC. Proceeds from Common Stock Issued
THERABIOGEN, INC. reported Proceeds from Common Stock Issued of $234.00 thousand for the 12-month period ending 2012-02-29, per its 10-K/A filed 2012-07-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2012-07-23
- THERABIOGEN, INC. proceeds from issuance of common stock for the quarter ending 2012-02-29 was $151.00K, a 44.85% increase year-over-year.
- THERABIOGEN, INC. proceeds from issuance of common stock for the quarter ending 2011-11-30 was $0.00, a 100.00% decline year-over-year.
- THERABIOGEN, INC. proceeds from issuance of common stock for the quarter ending 2011-08-31 was $0.00.
- THERABIOGEN, INC. proceeds from issuance of common stock for the quarter ending 2011-05-31 was $83.00K.
- THERABIOGEN, INC. proceeds from issuance of common stock for fiscal 2012 was $234.00K, a 67.18% decline from fiscal 2011.
- THERABIOGEN, INC. proceeds from issuance of common stock for fiscal 2011 was $713.00K.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2012-02-29 | $151.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-07-18 | $151.00K derived: sum of 2 quarters · filed 2012-07-18 | $151.00K derived: sum of 3 quarters · filed 2012-07-18 | $234.00K 10-K/A · filed 2012-07-18 |
| 2011-11-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-01-17 | $0.00 derived: sum of 2 quarters · filed 2012-01-17 | $83.00K 10-Q · filed 2012-01-17 | $187.25K derived: sum of 4 quarters · filed 2012-07-23 |
| 2011-08-31 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-11-17 | $83.00K 10-Q/A · filed 2011-11-17 | $187.25K derived: sum of 3 quarters · filed 2012-07-23 | $453.25K derived: sum of 4 quarters · filed 2012-07-23 |
| 2011-05-31 | $83.00K 10-Q · filed 2012-07-23 | $187.25K derived: sum of 2 quarters · filed 2012-07-23 | $453.25K derived: sum of 3 quarters · filed 2012-07-23 | |
| 2011-02-28 | $104.25K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-07-18 | $370.25K derived: sum of 2 quarters · filed 2012-07-18 | $713.00K 10-K/A · filed 2012-07-18 | |
| 2010-11-30 | $266.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-01-17 | $608.75K 10-Q · filed 2012-01-17 | ||
| 2010-08-31 | $342.75K 10-Q/A · filed 2011-11-17 |